![Robert Hayes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Robert Hayes served as the Executive Director & Chief Scientific Officer at PYC Therapeutics Ltd. from 2017 to 2018.
Prior to that, he was the Senior Director-Protein Engineering at Johnson & Johnson (Austrial) Pty Ltd. and the Biologics Head at Amgen Australia Pty Ltd. Hayes holds a doctorate degree from Imperial College London and a graduate degree from University College London.
Former positions of Robert Hayes
| Companies | Position | End |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Chief Tech/Sci/R&D Officer | 30/11/2018 |
Johnson & Johnson (Austrial) Pty Ltd. | Corporate Officer/Principal | - |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Training of Robert Hayes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Australia Pty Ltd. | |
Johnson & Johnson (Austrial) Pty Ltd. |
- Stock Market
- Insiders
- Robert Hayes
